268 related articles for article (PubMed ID: 33457003)
1. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
2. Coiled-coil domain-containing protein 58 (CCDC58) is a novel prognostic biomarker correlated with mitochondrial functions in hepatocellular carcinoma.
Chen L; Zhang J; Yang Y; Shu J; Zheng J; Zhan X; Guo M
Am J Transl Res; 2023; 15(4):2568-2584. PubMed ID: 37193151
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
4. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
5. Decreased Expression of GLYATL1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma.
Deng L; Jiang H
Int J Gen Med; 2023; 16():3757-3768. PubMed ID: 37649851
[TBL] [Abstract][Full Text] [Related]
6. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
9. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
Li D; Chen B; Zeng Y; Wang H
Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
11. Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma.
Yang Y; Li J; Tang M; Nie B; Huang W
Cancer Manag Res; 2022; 14():1627-1639. PubMed ID: 35535267
[TBL] [Abstract][Full Text] [Related]
12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma.
Cai X; Deng J; Zhou J; Cai H; Chen Z
BMC Gastroenterol; 2021 Oct; 21(1):377. PubMed ID: 34649520
[TBL] [Abstract][Full Text] [Related]
14.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
15. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic biomarker:
Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Prognostic Biomarker
Zhao J; Yang Z; Tu M; Meng W; Gao H; Li MD; Li L
Front Oncol; 2021; 11():608641. PubMed ID: 34367941
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma.
Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G
Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
Cai X; Zhou J; Deng J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
[TBL] [Abstract][Full Text] [Related]
20. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.
Deng H; Zhang J; Zheng Y; Li J; Xiao Q; Wei F; Han W; Xu X; Zhang Y
Front Surg; 2022; 9():878648. PubMed ID: 36211267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]